Form 8-K - Current report:
SEC Accession No. 0001171520-22-000183
Filing Date
2022-03-01
Accepted
2022-03-01 16:04:55
Documents
14
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 eps10120.htm   iXBRL 8-K 26231
2 CLEARPOINT NEURO REPORTS FOURTH QUARTER AND FULL-YEAR 2021 RESULTS ex99-1.htm EX-99.1 77914
3 GRAPHIC clearpoint-logo.jpg GRAPHIC 54914
  Complete submission text file 0001171520-22-000183.txt   364964

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE clpt-20220301.xsd EX-101.SCH 3054
5 XBRL LABEL FILE clpt-20220301_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE clpt-20220301_pre.xml EX-101.PRE 22609
8 EXTRACTED XBRL INSTANCE DOCUMENT eps10120_htm.xml XML 3609
Mailing Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075
Business Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075 9499006833
ClearPoint Neuro, Inc. (Filer) CIK: 0001285550 (see all company filings)

EIN.: 582394628 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34822 | Film No.: 22697892
SIC: 3841 Surgical & Medical Instruments & Apparatus